american heart association glp 1 GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies The conversation around GLP-1 medications

Bastian BC, LeBoit PE, Pinkel D

Secondly, in order to preserve residual mitochondrial bioenergetics and positively regulate the body homeostasis/adaptation capacities of these patients, the manuscript will put forward an innovative therapeutic view for the management of the disease, based on a diet with a moderate intake of carbohydrates and enriched in proteins, the practice of exercises of suitable type and intensity and a potential use of dietary supplements (Table 1)

It isn't magic

Use tools like notebooks, apps, or smart scales to stay consistent

Few clinical studies have directly measured markers of mitophagy in humans

Guo P, Wang Z, Sun L, He Z, Li J, Geng J, et al